Previous close | 0.1500 |
Open | 0.1500 |
Bid | 0.0000 |
Ask | 2.2500 |
Strike | 60.00 |
Expiry date | 2024-05-17 |
Day's range | 0.1500 - 0.1500 |
Contract range | N/A |
Volume | |
Open interest | 204 |
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
Bio-Techne Corporation ( NASDAQ:TECH ) defied analyst predictions to release its quarterly results, which were ahead of...
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46. Bio-Techne Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Bio-Techne […]